PND29 Scenario Analyses on Major Impactful and Uncertain Inputs of the Cost-Effectiveness Model of Fremanezumab From a Healthcare System Perspective in England
Abstract
Authors
A. Skroumpelos M. Freddi H. Akcicek J. Cohen M.T. Driessen